Recently, we reported that high levels of transforming growth factor (TGF)-β-specific T cells at baseline were associated with clinical benefit and improved survival in patients with pancreatic cancer in the CheckPAC study [9]. Here, TGFB1 is linked to pancreatic neoplasm.